Goldman Sachs Added Novartis AG (NVS) To Buy List, GlaxoSmithKline (GSK) To Sell List

March 18, 2009 8:18 AM EDT

Goldman Sachs added Novartis AG (NYSE: NVS) to its Conviction Buy List and added GlaxoSmithKline plc (NYSE: GSK) to its Conviction Sell List.


Related Categories

Analyst Comments

Stocks Mentioned

GSK 40.52

+0.06 +0.15%
Volume: 1,429,938
Track GSK

NVS 52.80

+0.22 +0.42%
Volume: 1,175,455
Track NVS


Related Entities


Add Your Comment